EUVIMEDEUVIMED entdecken
Leitlinie

NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024

Susan M Swetter, Douglas Johnson, Mark R Albertini, Christopher A Barker, Sarah Bateni, Joel Baumgartner, Shailender Bhatia, Christopher Bichakjian, Genevieve Boland, Sunandana Chandra, Bartosz Chmielowski, Dominick DiMaio und 26 weitere

Journal of the National Comprehensive Cancer Network · 2024-07 · 22 (5) · 290-298

DOI: 10.6004/jnccn.2024.0036 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2024-07. Verfasst von Susan M Swetter und 37 weiteren Autor:innen. Beteiligte Einrichtung: Stanford Cancer Institute. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms. Die Arbeit wurde bisher 174-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The NCCN Guidelines for Cutaneous Melanoma (termed Melanoma: Cutaneous ) provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients. These NCCN Guidelines Insights focus on the update to neoadjuvant systemic therapy options and summarize the new clinical data evaluated by the NCCN panel for the recommended therapies in Version 2.2024 of the NCCN Guidelines for Cutaneous Melanoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaSkin NeoplasmsHumansNeoplasm StagingMedical Oncology

Autor:innen und Institutionen

  • Stanford Cancer Institute.
  • Vanderbilt-Ingram Cancer Center.
  • University of Wisconsin Carbone Cancer Center.
  • Memorial Sloan Kettering Cancer Center.
  • O'Neal Comprehensive Cancer Center at UAB.
  • UC San Diego Moores Cancer Center.

Zitieren

APA

Swetter, S. M., Johnson, D., Albertini, M. R., Barker, C. A., Bateni, S., Baumgartner, J., Bhatia, S., Bichakjian, C., Boland, G., Chandra, S., Chmielowski, B., DiMaio, D., Dronca, R., Fields, R. C., Fleming, M. D., Galan, A., Guild, S., Hyngstrom, J., Karakousis, G., …, & Espinosa, S. (2024). NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024. Journal of the National Comprehensive Cancer Network, 22(5), 290-298. https://doi.org/10.6004/jnccn.2024.0036

Vancouver

Swetter SM, Johnson D, Albertini MR, Barker CA, Bateni S, Baumgartner J, et al. NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024. Journal of the National Comprehensive Cancer Network. 2024;22(5):290-298. doi:10.6004/jnccn.2024.0036

BibTeX
@article{Swetter2024,
  author = {Swetter, Susan M and Johnson, Douglas and Albertini, Mark R and Barker, Christopher A and Bateni, Sarah and Baumgartner, Joel and Bhatia, Shailender and Bichakjian, Christopher and Boland, Genevieve and Chandra, Sunandana and Chmielowski, Bartosz and DiMaio, Dominick and Dronca, Roxana and Fields, Ryan C and Fleming, Martin D and Galan, Anjela and Guild, Samantha and Hyngstrom, John and Karakousis, Giorgos and Kendra, Kari and Kiuru, Maija and Lange, Julie R and Lanning, Ryan and Logan, Theodore and Olson, Daniel and Olszanski, Anthony J and Ott, Patrick A and Ross, Merrick I and Rothermel, Luke and Salama, April K and Sharma, Rohit and Skitzki, Joseph and Smith, Emily and Tsai, Katy and Wuthrick, Evan and Xing, Yan and McMillian, Nicole and Espinosa, Sara},
  title = {NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2024},
  volume = {22},
  number = {5},
  pages = {290--298},
  doi = {10.6004/jnccn.2024.0036}
}
Kostenlos starten →